Insider · CIK 0001676880

Cooper Ronald Harold Wilfred

Reports to the SEC for 5 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001676880

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+62K sh	—	—	62,000
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−950 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,920 sh	—	—	0
2026-01-30	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+801K sh	—	—	801,000
2025-06-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.5K sh	—	—	35,500
2025-06-04	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-01-29	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+850K sh	—	—	850,000
2024-09-27	ENGNenGene Therapeutics Inc.P Purchase	Director, CEO & President	PPurchase	+10K sh	$5.70	+$57K	10,000
2024-07-22	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+1.25M sh	—	—	1,250,000
2024-06-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2024-06-06	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2023-06-08	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−124K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−33.1K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−132K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−43K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−93K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−124K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−124K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−60K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−19.4K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−155K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−219K sh	—	—	0
2023-01-23	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−1,057 sh	$43.80	−$46.3K	57,444
2023-01-19	ALBIREO PHARMA, INC.A Award	Director, President and CEO	AAward	+195K sh	—	—	252,444
2023-01-19	ALBIREO PHARMA, INC.A Award	Director, President and CEO	AAward	+195K sh	—	—	252,444
2023-01-05	GBIOGeneration Bio Co.A Award	Director	AAward	+9,500 sh	$5.12	+$48.6K	9,500
2022-10-24	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−919 sh	$19.58	−$18K	58,501
2022-10-24	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−919 sh	$19.58	−$18K	55,461
2022-07-22	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−929 sh	$24.67	−$22.9K	56,380
2022-06-09	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,200
2022-04-22	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−907 sh	$33.11	−$30K	56,082
2022-01-24	ALBIREO PHARMA, INC.S Sale	Director, President and CEO	SSale	−3,684 sh	$24.88	−$91.7K	56,989
2022-01-18	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+132K sh	—	—	132,150
2021-09-17	ALBIREO PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12K sh	$19.19	+$230K	68,433
2021-09-17	ALBIREO PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−7,760 sh	$29.61	−$230K	60,673
2021-09-17	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12K sh	—	—	43,027
2021-03-01	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-01-21	ALBIREO PHARMA, INC.A Award	Director, President and CEO	AAward	+48.7K sh	—	—	56,460
2021-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+93K sh	—	—	93,000
2020-06-18	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+124K sh	—	—	124,000
2019-07-18	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+5,625 sh	—	—	5,625
2019-01-22	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+124K sh	—	—	124,000
2018-11-13	ALBIREO PHARMA, INC.P Purchase	Director, President and CEO	PPurchase	+1,026 sh	$25.02	+$25.7K	7,760
2018-08-14	ALBIREO PHARMA, INC.P Purchase	Director, President and CEO	PPurchase	+200 sh	$32.50	+$6,500	6,734

Recent filings

Accepted (ET)
Jun 264
Cooper Ronald Harold Wilfred0001470831-26-000663
SEC(opens sec.gov)
Feb 94
Cooper Ronald Harold Wilfred0001104659-26-012189
SEC(opens sec.gov)
Feb 34
Cooper Ronald Harold Wilfred0000929638-26-000480
SEC(opens sec.gov)
Jun 204
Cooper Ronald Harold Wilfred0001662579-25-000043
SEC(opens sec.gov)
Jun 64
Cooper Ronald Harold Wilfred0001415889-25-015986
SEC(opens sec.gov)
Jan 314
Cooper Ronald Harold Wilfred0000929638-25-000476
SEC(opens sec.gov)
Oct 14
Cooper Ronald Harold Wilfred0000929638-24-003358
SEC(opens sec.gov)
Jul 244
Cooper Ronald Harold Wilfred0000929638-24-002577
SEC(opens sec.gov)
Jun 114
Cooper Ronald Harold Wilfred0001662579-24-000046
SEC(opens sec.gov)
Jun 104
Cooper Ronald Harold Wilfred0001415889-24-016182
SEC(opens sec.gov)
Jun 124
Cooper Ronald Harold Wilfred0001415889-23-009606
SEC(opens sec.gov)
Mar 24
Cooper Ronald Harold Wilfred0001209191-23-014778
SEC(opens sec.gov)

Companies

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120

WATERTOWN, MA, 02472